Advertisement

International Journal of Legal Medicine

, Volume 123, Issue 3, pp 213–219 | Cite as

Chemical submission: results of 4-year French inquiry

  • S. Djezzar
  • F. Questel
  • E. Burin
  • S. Dally
  • the French Network of Centers for Evaluation and Information on Pharmacodependence
Original Article

Abstract

Psychoactive substances may be administered without the knowledge of a victim in order to induce incapacitation and thus facilitate criminal actions. The characteristics of the victims and the drugs used in such suspected chemical submissions (CS) were analyzed in 309 cases collected from October 2003 to December 2007 through a national survey. Out of 309 cases, 158 met all criteria of CS. The victims were mostly female (n = 89, 56%). The type of aggression was mostly sexual assault (in 79 cases 50%). Benzodiazepines and related drugs were detected in 129 victims (82%) and were mostly clonazepam, zolpidem, and bromazepam whereas flunitrazepam and gamma hydroxybutyrate, well known for their use in CS, were identified in 11 (7%) and five (3%) of the 158 victims. CS is not an anecdotal phenomenon in France. Information for health professionals and workers in forensic structures as well as education of the general population associated with preventive measures such as drug dosage form changes should contribute to improved care management of victims and decreased risk.

Keywords

Chemical submission Rape drugs Drugs criminal use Benzodiazepines 

Notes

Acknowledgments

This study was supported by the Agence Française de Sécurité Sanitaire des Produits de Santé and by the Mission Interministérielle de Lutte contre la Drogue et la Toxicomanie.

Network of Centres d'évaluation et d'information sur la pharmacodépendance, centres anti-poisons, centres régionaux de pharmacovigilance: J. Arditti (Marseille)—C.E. Barjhoux (Grenoble)—A. Boucher (Lyon)—J.H. Bourdon (Marseille)—A. Buisine (Paris)—M. Debrus (Paris)—D. Debruyne (Caen)—D. Fompeydie (Paris)—M. Galliot-Guilley (Paris)—R. Garnier (Paris)—V. Gibaja (Nancy)—M. Gony (Toulouse)—H Gourlain (Paris)—F. Haramburu (Bordeaux)—P. Harry (Angers)—P. Jolliet (Nantes)—M. Lapeyre-Mestre (Toulouse)—R. Leboisselier (Caen)—M. Mallaret (Grenoble)—H. Peyriere (Montpellier)—V. Pinzani (Montpellier)—A. Roussin (Toulouse)—I. Sec (Paris)—C. Vigneau (Nantes).

Agence Française de Sécurité Sanitaire des Produits de Santé (AFSSAPS): M.A. Courné, N. Richard.

In addition to the named authors, the following persons also participated in the study:

J.C. Alvarez; CHU Raymond Poincaré—E. Baccino; Hôpital Lapeyronie—N. Bourokba; CHU Raymond Poincaré—P. Chariot; GHU Nord Jean Verdier—F. Chastang; Hôpital Côte de Nacre—P. Dalmon; CH de Chambery—J.M. Devaux; Laboratoire Toxlab—H. Eysseric; CHU de Grenoble—L. Fournier; CHU Hôtel Dieu—Y. Gaillard; Laboratoire d’Analyse et de Toxicologie—C. Ganière-Monteil; CHU Hôtel-Dieu - J.M. Gaulier; CHU de Limoges—M.F. Kergueris; CHU Hôtel-Dieu—M. Lavit; Hôpital Purpan—C. Le Meur; Laboratoire Lumière—J.C. Mathieu-Daude; Hôpital Lapeyronie—P. Murat; CHU de Poitiers—G. Pépin; Laboratoire Toxlab—P. Plaisance; GH Lariboisière-Fernand Widal—D. Resiere; GH Lariboisière-Fernand Widal—C. Rey-Salmon; Unité médico-judiciaire Pédiatrique, CHU Trousseau—D. Richard; CHU de Clermont—Ferrand - C. Sayag; Hôpital Purpan—V. Scolan; CHU de Grenoble—N. Vinneman; Hôpital Purpan—P. Werson; CH Sud-Francilien.

References

  1. 1.
    Goldstein RL (1992) The Mickey Finn defense: involuntary intoxication and insanity. Bull Am Acad Psychiatr Law 20:27–31Google Scholar
  2. 2.
    Bismuth C, Dally S, Borron SW (1997) Chemical submission: GHB, benzodiazepines and other knock out drops. J Toxicol Clin Tox 35:595–598Google Scholar
  3. 3.
    Djezzar S, Arditti J (2004) La soumission chimique. J Eur Urgences (JEUR) 17:219–230Google Scholar
  4. 4.
    Brahams D (1989) Benzodiazepine sedation and allegations of sexual assault. Lancet 10(8650):1339–1340CrossRefGoogle Scholar
  5. 5.
    Gaulier JM, Fonteau F, Jouanel E, Lachatre G (2004) Rape drugs: pharmacological and analytical aspects. Ann Biol Clin 62:529–538Google Scholar
  6. 6.
    Papadodima SA, Athanaselis SA, Spiliopoulou C (2007) Toxicological investigations of drug-facilitated sexual assaults. Int J Clin Pract 61(2):259–264PubMedCrossRefGoogle Scholar
  7. 7.
    Anglin D, Spears KL, Hutson HR (1997) Flunitrazepam and its involvement in date or acquaintance rape. Acad Emerg Med 4:323–326PubMedCrossRefGoogle Scholar
  8. 8.
    ElSohly MA, Salamone SJ (1999) Prevalence of drugs used in cases of alleged sexual assault. J Anal Toxicol 23:141–146PubMedGoogle Scholar
  9. 9.
    Bosman IJ, Lusthof KJ (2003) Forensic cases involving the use of GHB in The Netherlands. Forensic Sci Int 133:17–21PubMedCrossRefGoogle Scholar
  10. 10.
    Varela M, Nogué S, Oros M, Miro O (2004) Gamma hydroxybutyrate use for sexual assault. Emerg Med J 21:255–256PubMedCrossRefGoogle Scholar
  11. 11.
    Slaughter L (2000) Involvement of drugs in sexual assault. J Reprod Med 45:425–430PubMedGoogle Scholar
  12. 12.
    Smith KM (1999) Drugs used in acquaintance rape. J Am Pharm Assoc (Wash) 39:519–525Google Scholar
  13. 13.
    Lusthof KL, Lameijer W, Zweipfenning PGM (2000) Use of clonidine for chemical submission. Clin Toxicol 38:329–332CrossRefGoogle Scholar
  14. 14.
    Vasseur P (2000) Agression sexuelle après soumission médicamenteuse. Méd Lég Hosp 3:94Google Scholar
  15. 15.
    Ghorbal H, Hamouda C, Bousnina M, Hédhiri S, Ben Salah N, Amamou M, Hédhili A (2003) Use of plants to induce chemical submission in Tunisia. Vet Hum Toxicol 45:91–93PubMedGoogle Scholar
  16. 16.
    Hurley M, Parker H, Wells DL (2006) The epidemiology of drug facilitated sexual assault. J Clin Forensic Med 13(4):181–185PubMedCrossRefGoogle Scholar
  17. 17.
    Juhascik MP, Negrusz A, Faugno D, Ledray L, Greene P, Lindner A, Haner B, Gaensslen RE (2007) An estimate of the proportion of drug-facilitation of sexual assault in four U.S. localities. J Forensic Sci 52(6):1396–1400PubMedGoogle Scholar
  18. 18.
    Boussairi A, Dupeyron JP, Hernandez B, Delaitre H, Beugnet L, Espinoza P, Diamant-Berger O (1996) Urine benzodiazepines screening of involuntarily drugged and robbed or raped patients. J Toxicol Clin Toxicol 34:721–724PubMedGoogle Scholar
  19. 19.
    Marc B, Baudry F, Vaquero P, Zerrouki L, Hassnaoui S, Douceron H (2000) Sexual assault under benzodiazepine submission in a Paris suburb. Arch Gynecol Obstet 263:193–197PubMedCrossRefGoogle Scholar
  20. 20.
    Questel F, Bécour B, Dupeyron JP, Galliot-Guilley M, Diamant-Berger O (2000) Medicinal submission: 4 years of experience at the UMJ of Paris. Med Leg Droit Med 43:459–465Google Scholar
  21. 21.
    Journal Officiel n°0289 du 13 décembre 2007. Décision du 27 novembre 2007 portant création à l’Agence française de sécurité sanitaire des produits de santé d’un groupe de travail « Recommandations galéniques et préventions du détournement des médicaments »Google Scholar
  22. 22.
    Société Française de Toxicologie Analytique (SFTA) (2003) Consensus for toxicological investigations of drug-facilitated crimes. Ann Toxicol Anal 15:239–242CrossRefGoogle Scholar
  23. 23.
    Modelon H, Frauger E, Laurenceau D, Thirion X, Mallaret M, Micallef J; ŕeseau des CEIP (2007) Psychotropic drug addiction: consumption study of specific population by the survey OPPIDUM 2004 from the CEIP network. Therapie 62(4):337–346CrossRefGoogle Scholar
  24. 24.
    Pavlic M, Libiseller K, Grubwieser P, Schubert H, Rabl W (2007) Medicolegal aspects of tetrazepam metabolism. Int J Legal Med 121(3):169–174PubMedCrossRefGoogle Scholar
  25. 25.
    Ferrara SD, Frison G, Tedeschi L, Lebeau M (2001) Gamma-hydroxybutyrate (GHB) and related products. In: Lebeau M, Mozayani A (eds) Drug facilitated sexual assault: a forensic handbook. Academic Press, London, pp 107–126Google Scholar
  26. 26.
    Elliott SP (2003) Gamma hydroxybutyric acid (GHB) concentrations in humans and factors affecting endogenous production. Forensic Sci Int 133:9–16PubMedCrossRefGoogle Scholar
  27. 27.
    Scott-Ham M, Burton FC (2005) Toxicological findings in cases of alleged drug facilited sexual assault in the United Kingdom over 3 year period. J Clin Forensic Med 12(4):175–186PubMedCrossRefGoogle Scholar
  28. 28.
    Raymon L, Robertson M (2001) Hallucinogens. In: Lebeau M, Mozayani A (eds) Drug facilitated sexual assault: a forensic handbook. Academic Press, London, pp 127–147Google Scholar
  29. 29.
    LeBeau MA (2008) Guidance for improved detection of drugs used to facilitate crimes. Ther Drug Monit 30(2):229–233PubMedCrossRefGoogle Scholar
  30. 30.
    Garriott JC, Mozayani A (2001) Ethanol. In: Lebeau M, Mozayani A (eds) Drug facilitated sexual assault: a forensic handbook. Academic Press, London, pp 73–88Google Scholar
  31. 31.
    Gaillard Y, Masson-Seyer MF, Giroud M, Roussot JF, Prevosto JM (2006) A case of drug-facilitated sexual assault leading to death by chloroform poisoning. Int J Legal Med 120(4):241–245PubMedCrossRefGoogle Scholar
  32. 32.
    Australian institute of criminology (2004) National Project On Drink spiking: investigating the nature and extend of drink spiking in Australia. Efforts to prevent drink spiking. pp 117–125 http://www.aic.gov.au/publications/reports/2004-11-drinkspiking/refs.html

Copyright information

© Springer-Verlag 2008

Authors and Affiliations

  • S. Djezzar
    • 1
  • F. Questel
    • 2
  • E. Burin
    • 1
  • S. Dally
    • 1
  • the French Network of Centers for Evaluation and Information on Pharmacodependence
  1. 1.Pharmacodependence CenterHôpital Fernand Widal, Assistance Publique-Hôpitaux de ParisParisFrance
  2. 2.Forensic EmergenciesHôpital Hôtel Dieu, Assistance Publique-Hôpitaux de ParisParisFrance

Personalised recommendations